Stansberry’s Big Trade

Stansberry’s Big Trade is a longer-term monthly service that aims to profit from companies that are on fragile credit footing. Unlike Stanberry’s other products, this premium service isn’t about investing at all; it is all about speculating. Attempting to profit from market extremes, Big Trade focuses on stock prices that are going to drop significantly. And using a groundbreaking options trading strategy, your positions will rise as these companies fall. This service is built for subscribers who are comfortable with risk.


The Dirty Thirty

The first thing you’ll get is a list of the 30 companies we’ve identified as the worst credit risks in the market – what we call the “Dirty Thirty.” We’ll send you a comprehensive report featuring the full “Dirty Thirty” roster – including the name and ticker symbols of each of the companies we’re planning to target.

As the credit profiles of these companies change, so will the “Dirty Thirty” list. So every month, we’ll review the credit profile of every company on the list and notify you if we make any changes.

12 Monthly Issues of Stansberry’s Big Trade

We will send you a full report every month with a complete list of the companies on our watch list, as well as any updates to their credit status or risk. Monthly recommendations will vary – some months may have several recommendations while others may not have any.

Diversifying over time and across different companies allows you to take on the least amount of risk and to capture the biggest potential gains. If our recommendations hit one or two of these exactly right, you could make up to 5, 10 or 20 times your money over the next 3-5 years.

As an added benefit, you’ll have the chance to secure expensive “disaster insurance” to protect your portfolio in the event of a sudden correction or market crash.

The Stansberry Digest

Every weekday, the Stansberry Research editorial team writes up notes on interesting situations taking shape in the markets. This daily e-letter will keep you up-to-date on what’s going on with the Stansberry Research family: what we got right, what we got wrong, what we’ve got planned, and more.